Vikings Shipwreck: Morgan Stanley analysts have estimated that Lillys GLP-1 pill, when used to treat obesity and diabetes, could bring in as much as $40 billion in annual sales by 2033
Fecal Serine Protease Profiling in Inflammatory Bowel Diseases
2023: Lawsuits are filed against Novo Nordisk on behalf of patients who took the drugs and developed gastroparesis/stomach paralysis problems Pop Culture Weight Loss Phenomenon Is Paralyzing Peoples Stomachs FDA, Scientific Studies and Literature on Ozempic, Wegovy, and Rybelsus Gastroparesis/Stomach Paralysis The below studies constitute a small sampling of the scientific literature and studies published on the diabetes weight-loss drugs and gastroparesis/stomach paralysis: Jensterle et al (2023) : Semaglutide delays 4-hour gastric emptying in women with polycystic ovary syndrome and obesity This was a small clinical trial of 20 obese female patients with polycystic ovary syndrome who were given semaglutide or placebo
Besides weight reduction, patients often report higher energy levels, decreased joint pain, better sleep quality, heightened self-confidence, and lowered risks for heart disease and diabetes
Often, you'll have the neurological or psychological symptoms before the anemia (low red blood cell count) is present
Available from: [DOI] [PMC free article] [PubMed] [Google Scholar] 37
